Alcohol Dependence, Alcoholism, Alcohol Use Disorder
Conditions
Brief summary
Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.
Interventions
COMBINATION_PRODUCTRia Treatment Platform
combined medication, coaching, education, and monitoring
Sponsors
Ria Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Stanford University
University of Washington
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
participants will be randomly assigned in a 1:1 to the Ria Treatment Platform or a waitlist control condition
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* alcohol use disorder
Exclusion criteria
* inability to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percent of subjects without heavy drinking days | Final 4 weeks of the 12-week trial period | Heavy drinking is defined as 5 or more standard drinks per day for men and 4 or more standard drinks per day for women, as assessed by the Timeline Followback. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of abstinent days | 12-week trial period | Any drinking as assessed by the Timeline Followback |
| Liver function (ALT, AST, GGT) | 12 weeks | Measures of liver function. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORJohn Mendelson, MD
Ria Health
Outcome results
None listed